Divakar Sharma Selected Research

Kanamycin

7/2019	Role of M.tuberculosis protein Rv2005c in the aminoglycosides resistance.
1/2016	M. tuberculosis ferritin (Rv3841): Potential involvement in Amikacin (AK) & Kanamycin (KM) resistance.
1/2015	Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets.
12/2013	Proteomic analysis of Mycobacterium tuberculosis isolates resistant to kanamycin and amikacin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Divakar Sharma Research Topics

Disease

19	Tuberculosis (Tuberculoses) 01/2021 - 12/2013
8	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 12/2020 - 09/2015
7	Infections 01/2022 - 01/2019
4	COVID-19 07/2021 - 01/2021
2	Extensively Drug-Resistant Tuberculosis 01/2017 - 01/2016
1	Bacterial Infections (Bacterial Infection) 01/2022
1	Staphylococcal Infections 11/2021
1	Coronavirus Infections 01/2021
1	Measles 01/2021
1	Mumps 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	Rubella (German Measles) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Poliomyelitis (Polio) 01/2021
1	Leprosy (Hansen's Disease) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Pneumonia (Pneumonitis) 01/2019
1	Disease Resistance 08/2018
1	Inflammation (Inflammations) 07/2018
1	Heart Failure 07/2005
1	Myocardial Infarction 02/2005
1	ST Elevation Myocardial Infarction 02/2005

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
8	Pharmaceutical PreparationsIBA 11/2021 - 12/2016
6	AminoglycosidesIBA 07/2019 - 12/2013
4	VaccinesIBA 01/2021 - 01/2016
4	Kanamycin FDA Link 07/2019 - 12/2013
4	Amikacin (A.M.K)FDA LinkGeneric 07/2019 - 12/2013
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 07/2005
2	Ofloxacin (Ofloxacine)FDA LinkGeneric 01/2020 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2017
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2019 - 01/2019
1	carbapenemaseIBA 01/2022
1	Colistin (Coly-Mycin)FDA Link 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021
1	Angiotensin Receptor AntagonistsIBA 01/2021
1	Attenuated VaccinesIBA 01/2021
1	AcidsIBA 12/2020
1	Plant LectinsIBA 01/2020
1	CarbohydratesIBA 01/2020
1	thioforminIBA 01/2020
1	FluoroquinolonesIBA 01/2020
1	LectinsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	saccharide-binding proteinsIBA 01/2020
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019
1	Meropenem (Merrem)FDA LinkGeneric 01/2019
1	ProteomeIBA 01/2019
1	signal peptide receptorIBA 04/2018
1	GTP-Binding Proteins (G-Protein)IBA 04/2018
1	Streptomycin (Streptomycin Sulfate)FDA Link 12/2017
1	polyacrylamideIBA 10/2017
1	bedaquiline (R207910)IBA 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2017
1	IronIBA 01/2017
1	OPC-67683IBA 01/2017
1	PeroxidesIBA 01/2016
1	Peroxidase (Myeloperoxidase)IBA 01/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	cumene hydroperoxideIBA 01/2016
1	Antitubercular AgentsIBA 01/2015
1	Moxifloxacin (Avelox)FDA Link 01/2015
1	Captopril (Capoten)FDA LinkGeneric 07/2005
1	Losartan (Cozaar)FDA LinkGeneric 07/2005
1	Enoxaparin (Lovenox)FDA LinkGeneric 02/2005
1	AntithrombinsIBA 02/2005
1	Heparin (Liquaemin)FDA LinkGeneric 02/2005

Therapy/Procedure

13	Therapeutics 01/2022 - 02/2005
4	Drug Therapy (Chemotherapy) 01/2021 - 09/2015
2	Lasers (Laser) 10/2017 - 12/2016